Leishmaniasis

Leishmaniasis is a vector-borne disease that is transmitted by sandflies and caused by obligate intracellular protozoa of the genus Leishmania. Human infection is caused by about 21 of 30 species that infect mammals. Leishmaniasis is found about 88 countries. Approximately 350 million people live in these areas. Most of the affected countries are in the tropics and subtropics. For more information on the disease please visit the CDC Website.

Cellabs has produced a number of products for Leishmaniasis. They are currently undergoing regulatory review.
PLEASE NOTE THAT THESE PRODUCTS ARE FOR RESEARCH PURPOSES ONLY:


Cat No.
Kit Name
# of Tests
 Description
Brochure
KL1
Leishmania Cel
50
 IFA using a polyclonal antibody. Detects all Leishmania protozoa: promastigotes from sand-flies and in culture as well as amastigotes in human biopsy material.
KL2
Visceral Leishmania IgG Celisa
96
 ELISA test using novel antigen from cultivating L. donovani promastigotes in protein-free media. Detects parasite-specific IgG in human serum.
KL3
Cutaneous Leishmania IgG Celisa
96
 ELISA test using novel antigen from cultivating L. mexicana in protein-free media. Detects parasite-specific IgG in human serum.
KL4
Canine Leishmania Celisa
96
 ELISA test for the detection of parasite specfic IgG in canine serum.
Brochure Not Available
KL5
Canine Leishmania Cel
50
 Serological IFA test for the detection of parasite specific IgG from canine serum.
Brochure Not Available

The following are published articles using our Leishmania products:

Canine Leishmania IgG CELISA poster - Presented April 2005, World Leish Congress

Cutaneous Leishmania IgG CELISA poster - Presented April 2005, World Leish 3 Congress

Rajasekariah, GHR et al (2001) Optimisation of an ELISA for the serodiagnosis of visceral leishmaniasis using in vitro derived promastigote antigens. Journal of Immunological Methods. 252: pg 105-119

For more information on these products please contact Hubert Mazure.